-
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
Vai alla Pubblicazione -
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
Vai alla Pubblicazione -
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study
Vai alla Pubblicazione -
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis
Vai alla Pubblicazione -
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
Vai alla Pubblicazione -
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register.
Vai alla Pubblicazione
